BioCardia, Inc. (BCDA) Financials

BCDA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.7 million 2.8 million
Dec. 31, 2025 3.4 million 2.5 million
Sept. 30, 2025 6.1 million 3.5 million
June 30, 2025 2.1 million 4.0 million

BCDA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.7 million 113000
Dec. 31, 2025 -2.5 million 85000
Sept. 30, 2025 -1.7 million 77000
June 30, 2025 -1.7 million 98000

BCDA Net Income

No data available :(

BCDA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 951000 - 412000
Dec. 31, 2025 2.5 million - 86000
Sept. 30, 2025 5.3 million - 638000
June 30, 2025 980000 - 745000

BCDA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 10.8 million
Dec. 31, 2025 10.8 million
Sept. 30, 2025 6.3 million
June 30, 2025 5.1 million

BCDA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3000 1.2 million 1.0 million -
Dec. 31, 2025 6000 1.1 million 703000 -
Sept. 30, 2025 - 932000 449000 -
June 30, 2025 1000 1.4 million 683000 -

BCDA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 124000
Dec. 31, 2025 - 185000
Sept. 30, 2025 - 107000
June 30, 2025 - 1.4 million

BCDA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

BCDA

Price: $0.85

52 week price:
0.78
2.45

Earnings Per Share: -0.85 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 50500

Market Capitalization: 5.9 million

Links: